Pagetherapeutics
2 known investors
PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis. Its lead work includes preclinical models and a proof-of-concept clinical trial in breast cancer patients.
Founders & leadership
DS
Daniele ScarinciCEO & Executive Director
NA
Nicola AcetoCo-founder & Chief Science Officer
CR
Christoph RochlitzCo-founder & Chief Medical Officer
KV
Katharina VenturiChief Operating Officer